MONTREAL’S MÉDIMABS TO DISTRIBUTE REAGENT ANTIBODIES TO INTERNATIONAL MARKET Toronto, ON, Canada – The Centre for the Commercialization of Antibodies and Biologics (CCAB) and MédiMabs Antibodies have signed an agreement for the distribution of CCAB’s reagent antibodies. The agreement marks the launch of a new business segment for CCAB and allows MédiMabs to expand its portfolio to include human synthetic [...]

Combining the world-leading proteomic and artificial intelligence/machine learning technologies to produce novel, actionable health insights across many diseases, conditions and markets SomaLogic and GNS Healthcare announced today that SomaLogic has obtained a license to apply GNS Healthcare’s proprietary REFS™ (Reverse Engineering & Forward Simulation) causal machine learning technology to SomaLogic’s proprietary SOMAscan®-derived protein data sets. [...]

Researchers Will Receive Preferred Pricing and Early Access to New Technologies for Understanding the Blueprint for Life Provided by the Human Genome Project (HGP-read)   SAN JOSE, California Labcyte Inc. today announced an agreement with the Center for Excellence in Engineering Biology (CEEB), an independent nonprofit that is managing initial planning and coordination of efforts [...]

Oxford Instruments, the global leader in microanalysis systems, is proud to announce the most comprehensive range to date of Silicon Drift Detectors (SDD) for Energy Dispersive (EDS) analysis in the Scanning Electron Microscope.  New Ultim® Max 65mm2 and 40mm2 models have been released, to complete the Ultim range and join the 170mm2, 100mm2, and the unique ultra-high sensitivity [...]

labfolder and NEC announce smart and scalable data storage solution for research organizations  As scientists increasingly generate more data, large research institutions start facing a pressing need to manage research data efficiently. labfolder and NEC, two market leaders in their field, today announce a jointly developed solution to address this problem. Berlin 07/17/18 labfolder, a [...]

TUCSON, Ariz. -- PathogenDx Corporation, the innovative provider of DNA-based pathogen testing technology for the cannabis, botanical, food and agriculture industries, announced today the successful completion of a $3.4 million capital raise, completing the company's convertible note round. The PathogenDx capital raise was co-led by Altitude Investment Management and The Panther Opportunity Fund. Other key funders include CanopyVentures, Tendaji [...]

SAN FRANCISCO -- Enable Biosciences Inc was awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant for $750,000 to commercialize ultrasensitive and multiplexable immunoassays for both research and clinical diagnostic use. Over 70% of clinical decisions are informed by lab tests, many of which rely on detecting antibody biomarkers. "For hundreds of infectious and autoimmune diseases and cancer, early [...]

AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications. The latest tool in genome science – CRISPR/Cas9 is a simple and efficient genome editing tool which allows for specific genome disruption and replacement resulting in high specificity and low cell toxicity. AMSBIO CRISPR Complete kits are [...]

Cambridge, MA — BioData has announced the appointment of Steve Yemm as CEO, following a decade of growth in the adoption of its flagship product Labguru. This secure, compliant, web and cloud-based Electronic Lab Notebook (ELN) is trusted by over 30,000 users worldwide who rely on it to plan and document experiments, track progress, streamline lab [...]

Merck today announced a new research prize. The company will award the “Future Insight Prize” of up to € 1 million annually for the next 35 years. DARMSTADT, GERMANY First prize to be awarded 2019 for work on a visionary product to protect humanity from newly emerging viral diseases Merck committed to “Future Insight Prize” [...]